| Recruiting | Danish Vulva Cancer Recurrence Study NCT06495554 | University of Aarhus | N/A |
| Recruiting | Clinical Application of ctDNA Dynamic Monitoring in Neoadjuvant Therapy for HER2-positive Breast Cancer Patien NCT06479460 | The First Affiliated Hospital with Nanjing Medical University | — |
| Recruiting | ctDNA in CRC Patients Undergoing Curative-intent Surgery for Liver Metastases NCT05787197 | GERCOR - Multidisciplinary Oncology Cooperative Group | — |
| Unknown | Predicting the Efficacy and Prognosis of Rectal Cancer Patients Based on ctDNA-MRD Technology NCT05969938 | WeiWei Xiao | — |
| Unknown | ctDNA Methylation for Epithelial Ovarian Cancer NCT05801263 | Lei Li | — |
| Unknown | ctDNA Methylation for Detecting Ovarian Cancer NCT05801276 | Lei Li | — |
| Recruiting | Circulating Tumor DNA-guided Neoadjuvant Treatment Strategy for Locally Advanced Rectal Cancer NCT05601505 | Peking Union Medical College Hospital | Phase 2 |
| Recruiting | NSCLC Liquid Biopsies and Exhaled VOC NCT06707519 | St. Joseph's Healthcare Hamilton | — |
| Recruiting | Circulating Tumor DNA Guided Adjuvant Chemotherapy for Colon Cancer NCT05529615 | Peking University Cancer Hospital & Institute | N/A |
| Completed | Evaluation of the Technical Feasibility of Testing ct DNA for Homologous Recombination Gene Variants in Metast NCT05415787 | University Hospital, Tours | — |
| Unknown | Circulating Tumor DNA Guided Therapeutic Strategies for CRC Patients With Small Pulmonary Nodules NCT05495672 | Junjie Peng | N/A |
| Recruiting | Using ctDNA to Determine Therapies for Lung Cancer NCT04966663 | University Health Network, Toronto | Phase 2 |
| Unknown | Evaluation of Circulating Tumor DNA Guided Surveillance Strategy of Stage III Colorectal Cancer: an Open, Pros NCT05161585 | Fudan University | N/A |
| Unknown | Clinical Value of MRD Monitoring for Adjuvant Therapy in Postoperative NSCLC NCT05167604 | Tang-Du Hospital | — |
| Recruiting | Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-po NCT05598528 | Second Xiangya Hospital of Central South University | — |
| Recruiting | CtDNA as a Novel Biomarker of Treatment Efficacy in Patients With Ovarian Cancer NCT05027828 | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | — |
| Unknown | Cohort Study of Patients With Hepatocellular Carcinoma and Circulating Tumor DNA Monitoring of Chemoembolizati NCT05390112 | University Hospital, Rouen | — |
| Recruiting | Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer NCT04530890 | Poitiers University Hospital | N/A |
| Withdrawn | An Investigational Immuno-therapy Study of Nivolumab Given After Surgery in Non-Small Cell Lung Cancer (NSCLC) NCT03770299 | Bristol-Myers Squibb | Phase 2 |
| Unknown | Methylation Analysis of Circulating Tumor DNA in Gastric Cancer NCT04511559 | Shanghai Zhongshan Hospital | — |
| Unknown | The Value of ctDNA on Chemotherapy Efficacy for mCRC NCT04555369 | Fudan University | N/A |
| Completed | Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curat NCT04457297 | National Cancer Center Hospital East | Phase 3 |
| Recruiting | Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA) NCT04434040 | Dana-Farber Cancer Institute | Phase 2 |
| Completed | Reliability and Interest of Circulating Tumor DNA in Endometrial Cancers. NCT04456972 | Poitiers University Hospital | N/A |
| Recruiting | Circulating Tumor DNA Based Adjuvant Chemotherapy in Stage II Colon Cancer Patients: the MEDOCC-CrEATE Trial NCT06434896 | UMC Utrecht | N/A |
| Unknown | Clinical Sensitivity Verification Study of Circulating Tumor Cells Gene Mutation Detection From Advanced NSCLC NCT04229121 | Shanghai Pulmonary Hospital, Shanghai, China | — |
| Completed | Dynamic ctDNA Detection for Colorectal Cancer Liver Metastases NCT06404593 | Peking University Cancer Hospital & Institute | — |
| Unknown | IMPROVE Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative NCT03748680 | Karen-Lise Garm Spindler | Phase 2 |
| Unknown | Potential of Circulating Tumor DNA to Assess the Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer P NCT03688035 | Zhiyong Yu | — |
| Unknown | Dynamic Monitoring of ctDNA Methylation to Predict Relapse in Colorectal Cancer After Radical Resection (POSTC NCT03737539 | Fudan University | — |
| Completed | OPTImal PALliative Anti-epidermal Growth Factor Receptor Treatment in Metastatic Colorectal Cancer - NCT03750175 | Karen-Lise Garm Spindler | — |
| Unknown | Genetic Characteristics of HER2 Positive Breast Cancer With Neoadjuvant TCHP Chemotherapy NCT04276337 | Samsung Medical Center | — |
| Unknown | WHENII - Early Response Evaluation With FDG-PET/CT and Liquid Biopsy in Patients With NSCLC NCT03481101 | Rigshospitalet, Denmark | N/A |
| Unknown | Application of Circulating Tumor DNA Test in the Diagnosis and Treatment of Patients With Advanced Rectal Canc NCT03615170 | Zhejiang Cancer Hospital | — |
| Completed | Clinical Application of Circulating Tumor DNA (ctDNA) in Patients With Late-stage Breast Cancer NCT05079074 | Hunan Cancer Hospital | — |
| Completed | Circulating Tumor DNA (ctDNA)-Guided Late-Line Treatment in Patients With Late-Stage Breast Cancer NCT05427617 | Hunan Cancer Hospital | — |
| Completed | CIrculating Tumor DNA for Monitoring Response to First Line Chemotherapy in Unresectable PANcreatic Cancer NCT04560270 | Poitiers University Hospital | N/A |
| Completed | Concordance Between ctDNA Assay and FoundationOne NCT02620527 | Foundation Medicine | — |